nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anxiety in adults with allergic rhinitis during the coronavirus disease 2019 pandemic: A Canadian perspective
|
Xu, Kayley |
|
|
129 |
5 |
p. 627-634 |
artikel |
2 |
Delayed diagnosis of hereditary angioedema in the setting of Prader-Willi syndrome
|
Jalil, Maaz |
|
|
129 |
5 |
p. 643-644 |
artikel |
3 |
Editorial Board
|
|
|
|
129 |
5 |
p. A11 |
artikel |
4 |
Efficacy and safety of GSP301 nasal spray in children aged 6 to 11 years with seasonal allergic rhinitis
|
Prenner, Bruce M. |
|
|
129 |
5 |
p. 618-626.e2 |
artikel |
5 |
From the Pages of AllergyWatch
|
Fineman, Stanley M. |
|
|
129 |
5 |
p. 647-648 |
artikel |
6 |
High cost of immunoglobulin replacement therapy
|
Sun, Di |
|
|
129 |
5 |
p. 645 |
artikel |
7 |
Identifying and classifying patients with hypersensitivity pneumonitis as fibrotic or nonfibrotic instead of as acute, subacute, or chronic
|
Greenberger, Paul A. |
|
|
129 |
5 |
p. 544-545 |
artikel |
8 |
Immunizing the imperfect immune system
|
Durkee-Shock, Jessica R. |
|
|
129 |
5 |
p. 562-571.e1 |
artikel |
9 |
Immunoglobulin replacement therapy stewardship in modern times
|
Wasserman, Richard L. |
|
|
129 |
5 |
p. 546-547 |
artikel |
10 |
Inborn errors of immunity associated with elevated immunoglobulin E
|
Khan, Yasmin W. |
|
|
129 |
5 |
p. 552-561 |
artikel |
11 |
Industry payments to allergists and clinical immunologists in the United States during the coronavirus disease 2019 pandemic
|
Murayama, Anju |
|
|
129 |
5 |
p. 635-636 |
artikel |
12 |
Information for Readers
|
|
|
|
129 |
5 |
p. A1 |
artikel |
13 |
November 2022 (Primary Immune Deficiency)
|
|
|
|
129 |
5 |
p. 579 |
artikel |
14 |
Omalizumab for treatment of idiopathic angioedema
|
Goswamy, Vinay P. |
|
|
129 |
5 |
p. 605-611.e1 |
artikel |
15 |
Outcomes of simulation-based anaphylaxis education in a diverse group of participants
|
Aquino, Marcella R. |
|
|
129 |
5 |
p. 638-640 |
artikel |
16 |
Patient-oriented measures for phase 3 studies of tralokinumab for the treatment of atopic dermatitis (ECZTRA 1, 2, and 3)
|
Simpson, Eric L. |
|
|
129 |
5 |
p. 592-604.e5 |
artikel |
17 |
Prevalence and associations among metabolically unhealthy obesity, asthma exacerbations, and emergency department use
|
Greiner, Benjamin |
|
|
129 |
5 |
p. 580-584.e2 |
artikel |
18 |
Safety of subcutaneous immunotherapy in patients with severe asthma
|
Chow, Timothy G. |
|
|
129 |
5 |
p. 585-591.e3 |
artikel |
19 |
Social media as a public health initiative
|
Tam, Jonathan S. |
|
|
129 |
5 |
p. 540-541 |
artikel |
20 |
Specific antibody deficiency: pearls and pitfalls for diagnosis
|
Lawrence, Monica G. |
|
|
129 |
5 |
p. 572-578 |
artikel |
21 |
Swelling without hives and normal complement
|
Lieberman, Jay Adam |
|
|
129 |
5 |
p. 539 |
artikel |
22 |
Systemic sclerosis and hypereosinophilic syndrome in a 3-year-old child
|
Allen, Jennifer |
|
|
129 |
5 |
p. 548-551 |
artikel |
23 |
Table of Contents
|
|
|
|
129 |
5 |
p. A3-A5 |
artikel |
24 |
Temporal variation of tryptase and interlaboratory variability
|
Ritter, Shaunah |
|
|
129 |
5 |
p. 640-642 |
artikel |
25 |
The intersection of the sunshine act, sutton's law, and the pandemic
|
Shaker, Marcus |
|
|
129 |
5 |
p. 542-543 |
artikel |
26 |
The nose: The silent zone of scientific research
|
Giancaspro, Rossana |
|
|
129 |
5 |
p. 646 |
artikel |
27 |
Type 2 biologics reduce cumulative steroid exposure in aspirin-exacerbated respiratory disease
|
Ghiasi, Yasamin |
|
|
129 |
5 |
p. 642-643 |
artikel |
28 |
Update in primary immune deficiencies for the practicing allergist/clinical immunologist
|
Adam Lieberman, Jay |
|
|
129 |
5 |
p. 537-538 |
artikel |
29 |
Use of over-the-counter inhaled epinephrine in asthma
|
Biggs, Sarah E. |
|
|
129 |
5 |
p. 637-638 |
artikel |
30 |
YouTube as a source of (mis)information on allergic rhinitis
|
Remvig, Celine Lund-Nielsen |
|
|
129 |
5 |
p. 612-617 |
artikel |